MIT Engineers Develop Heat-Resistant RNA Vaccine Formulation Using AI

Engineers at MIT have discovered a method to stabilize the lipid nanoparticles used in RNA vaccines, potentially allowing for wider distribution by eliminating the need for ultracold storage. Utilizing an AI algorithm, researchers tweaked the formulation around the lipid nanoparticles, creating vaccines that remained stable at room temperature for up to a year, or at nearly 100 degrees Fahrenheit for two months. This approach significantly reduces the number of experiments needed for development and could materially influence future vaccine research and accessibility.